Kazuya Abe

Improvement of Nasal Bioavailability of Luteinizing Hormone-Releasing Hormone Agonist, Buserelin, by Cyclodextrin Derivatives in Rats

Kazutaka Matsubara, Kazuya Abe, Tetsumi Irie et al. · Journal of Pharmaceutical Sciences · 1995 · 75 citations

Endocrine Mechanism, Nasal Bioavailability, Medicine +8

An "intelligent" workstation for computer-aided diagnosis.

Maryellen L. Giger, Kazuteru Doi, Heber MacMahon et al. · Radiographics · 1993 · 54 citations

Engineering, Intelligent Diagnostics, Diagnosis +20

Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis

Tomoaki Ida, Shunsuke Furuta, Asuka Takayama et al. · RMD Open · 2023 · 48 citations · Full text

Mda5-dm Patients Refractory, Immunology, Pharmacotherapy +20

Isolated abducens nerve palsy caused by vascular compression

Hisashi Narai, Yoshie Manabe, Kōichi Deguchi et al. · Neurology · 2000 · 35 citations

Vascular Compression, Horizontal Diplopia, Ophthalmology +11

Enhanced Nasal Delivery of Luteinizing Hormone Releasing Hormone Agonist Buserelin by Oleic Acid Solubilized and Stabilized in Hydroxypropyl-.BETA.-cyclodextrin.

Kazuya Abe, Tetsumi Irie, Kaneto Uekama · Chemical and Pharmaceutical Bulletin · 1995 · 34 citations · Full text

Pharmaceutical Science, Enhanced Nasal Delivery, Oleic Acid +14